The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 3)
Research Grant, 2018
Mutations in the LRRK2 gene can cause Parkinson's disease (PD), and therapies against associated dysfunction in the LRRK2 protein are in clinical trials. A specific variant of the LRRK2 gene (G2385R) is found in almost one-tenth of Asian people with PD. Genetics is an important window to better understand disease -- even in those without these mutations -- and trials need volunteer...
Researchers: Caroline Tanner, MD, PhD
Rapid Response Innovation Awards, 2013
The goals of the project are to identify a unique set of DNA modifications (methylation) in brain sections of those with and without Parkinson's disease (PD), exposed to organochlorine and/or plantation work. Both exposures have been shown to be risk factors for PD in this Japanese male population. A secondary objective is to see if these same DNA modifications will be reflect...
Researchers: Rodney Chun Pung Go, PhD
Cell Replacement Therapy, 2004
Transplanation of Cell-Derived Dopaminergic Neurons Into the Brains of MPTP-treated Pre-clinical Models
Previous work has identified a stromal cell-derived inducing activity (SDIA) in a stromal cell line (PA6 cells) that can induce mouse and primate ES cells to differentiate into mid/hindbrain neurons, dopaminergic (DA) neurons in particular. In our previous study, these SDIA-treated pre-clinical model ES cells have been transplanted into the brains of MPTP-treated pre-clinical models of Parkinson's...
Researchers: Jun Takahashi, MD, PhD